Dr Coxon studied undergraduate biochemistry at the University of Bath. She then obtained a PhD from the University of Reading in cardiovascular science and myocardial regeneration, moving then to the University of Oxford to characterise a novel platelet receptor, G6b in the laboratory of Dr Duncan Campbell. During this time she lead collaborative projects pertaining to pharmacology and drug discovery, as well specialising in biochemical and biophysical approaches to studying protein-protein interactions. Subsequent positions at the Weatherall Institute of Molecular Medicine (Oxford), the Dept. Physiology, Pharmacology and Neuroscience in Bristol, and the Target Discovery Institute (Structural Genomics Consortium, Oxford) further developed her expertise in biochemistry, biophysical assays, and drug discovery.
Dr Coxon has long been interested in cardiovascular disease, specifically aspects of thrombosis and haemostasis, and she is keen to scientifically contribute to improving the quality and application of therapeutics used to treat bleeding disorders. Working with Dr Sanj Raut, as a Post-Doctoral Fellow, she is currently engaged in the development and implementation of reference materials aimed at reducing the unacceptably high variability in haemophilia A inhibitor testing.